MedTrace Logo

AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction

NCT00275990 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 501

Last updated 2014-10-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether prompt removal of thrombus (blood clot) from a blocked coronary artery using the AngioJet rheolytic thrombectomy device will result in improved blood flow within the heart and a smaller final infarct size (reduced injury to the heart muscle).

Conditions

Interventions

DEVICE

rheolytic thrombectomy with direct stenting

DEVICE

direct stenting

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • David Antoniucci, MD · Azienda Ospedaliero-Universitaria Careggi, Florence, ITALY

  • Antonio Colombo, MD · San Raffaelle Hospital, Milan ITALY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2009-10-31
Completion
2010-08-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00275990 on ClinicalTrials.gov